$NGM Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NGM BIOPHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in NGM BIOPHARMACEUTICALS INC. Get notifications about new insider transactions in NGM BIOPHARMACEUTICALS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jul 23 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.35 | 30,760 | 410,535 | 2,244,714 | 2.2 M to 2.2 M (+1.39 %) |
Jul 23 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.54 | 30,760 | 416,337 | 2,213,954 | 2.2 M to 2.2 M (+1.41 %) |
Jul 23 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.99 | 6,222 | 87,043 | 2,183,194 | 2.2 M to 2.2 M (+0.29 %) |
Jul 17 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.86 | 3,900 | 54,055 | 15,936,063 | 15.9 M to 15.9 M (+0.02 %) |
Jul 17 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.69 | 16,188 | 221,547 | 15,932,163 | 15.9 M to 15.9 M (+0.10 %) |
Jul 17 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.86 | 3,900 | 54,055 | 15,746,063 | 15.7 M to 15.7 M (+0.02 %) |
Jul 17 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.69 | 16,188 | 221,547 | 15,742,163 | 15.7 M to 15.7 M (+0.10 %) |
Jul 17 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.86 | 3,900 | 54,055 | 2,176,972 | 2.2 M to 2.2 M (+0.18 %) |
Jul 17 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.69 | 16,188 | 221,547 | 2,173,072 | 2.2 M to 2.2 M (+0.75 %) |
Jul 15 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.88 | 21,014 | 291,765 | 15,725,975 | 15.7 M to 15.7 M (+0.13 %) |
Jul 15 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.87 | 10,870 | 150,752 | 15,704,961 | 15.7 M to 15.7 M (+0.07 %) |
Jul 15 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.88 | 21,014 | 291,765 | 2,156,884 | 2.1 M to 2.2 M (+0.98 %) |
Jul 15 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.87 | 10,870 | 150,752 | 2,135,870 | 2.1 M to 2.1 M (+0.51 %) |
Jul 15 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.88 | 21,014 | 291,765 | 15,915,975 | 15.9 M to 15.9 M (+0.13 %) |
Jul 15 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.87 | 10,870 | 150,752 | 15,894,961 | 15.9 M to 15.9 M (+0.07 %) |
Jul 15 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.88 | 21,014 | 291,765 | 15,915,975 | 15.9 M to 15.9 M (+0.13 %) |
Jul 15 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.87 | 10,870 | 150,752 | 15,894,961 | 15.9 M to 15.9 M (+0.07 %) |
Jun 26 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.78 | 12,240 | 168,650 | 15,884,091 | 15.9 M to 15.9 M (+0.08 %) |
Jun 26 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.78 | 12,240 | 168,650 | 15,694,091 | 15.7 M to 15.7 M (+0.08 %) |
Jun 26 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.78 | 12,240 | 168,650 | 2,125,000 | 2.1 M to 2.1 M (+0.58 %) |
Jun 21 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 14.03 | 3,763 | 52,789 | 15,871,851 | 15.9 M to 15.9 M (+0.02 %) |
Jun 21 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.86 | 15,400 | 213,385 | 15,868,088 | 15.9 M to 15.9 M (+0.10 %) |
Jun 21 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.91 | 15,214 | 211,674 | 15,852,688 | 15.8 M to 15.9 M (+0.10 %) |
Jun 21 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 14.03 | 3,763 | 52,789 | 15,681,851 | 15.7 M to 15.7 M (+0.02 %) |
Jun 21 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.86 | 15,400 | 213,385 | 15,678,088 | 15.7 M to 15.7 M (+0.10 %) |
Jun 21 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.91 | 15,214 | 211,674 | 15,662,688 | 15.6 M to 15.7 M (+0.10 %) |
Jun 21 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 14.03 | 3,763 | 52,789 | 2,112,760 | 2.1 M to 2.1 M (+0.18 %) |
Jun 21 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.86 | 15,400 | 213,385 | 2,108,997 | 2.1 M to 2.1 M (+0.74 %) |
Jun 21 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.91 | 15,214 | 211,674 | 2,093,597 | 2.1 M to 2.1 M (+0.73 %) |
Jun 14 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 14.00 | 10,760 | 150,687 | 15,837,474 | 15.8 M to 15.8 M (+0.07 %) |
Jun 14 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 14.13 | 11,500 | 162,508 | 15,826,714 | 15.8 M to 15.8 M (+0.07 %) |
Jun 14 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 14.00 | 7,500 | 104,989 | 15,815,214 | 15.8 M to 15.8 M (+0.05 %) |
Jun 14 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 14.00 | 10,760 | 150,687 | 15,647,474 | 15.6 M to 15.6 M (+0.07 %) |
Jun 14 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 14.13 | 11,500 | 162,508 | 15,636,714 | 15.6 M to 15.6 M (+0.07 %) |
Jun 14 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 14.00 | 7,500 | 104,989 | 15,625,214 | 15.6 M to 15.6 M (+0.05 %) |
Jun 14 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 14.00 | 10,760 | 150,687 | 2,078,383 | 2.1 M to 2.1 M (+0.52 %) |
Jun 14 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 14.13 | 11,500 | 162,508 | 2,067,623 | 2.1 M to 2.1 M (+0.56 %) |
Jun 14 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 14.00 | 7,500 | 104,989 | 2,056,123 | 2 M to 2.1 M (+0.37 %) |
Jun 11 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.83 | 10,900 | 150,718 | 15,807,714 | 15.8 M to 15.8 M (+0.07 %) |
Jun 11 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.66 | 12,600 | 172,176 | 15,796,814 | 15.8 M to 15.8 M (+0.08 %) |
Jun 11 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.83 | 10,900 | 150,718 | 15,617,714 | 15.6 M to 15.6 M (+0.07 %) |
Jun 11 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.66 | 12,600 | 172,176 | 15,606,814 | 15.6 M to 15.6 M (+0.08 %) |
Jun 11 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.83 | 10,900 | 150,718 | 2,048,623 | 2 M to 2 M (+0.53 %) |
Jun 11 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.66 | 12,600 | 172,176 | 2,037,723 | 2 M to 2 M (+0.62 %) |
Jun 06 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.40 | 12,600 | 168,884 | 15,784,214 | 15.8 M to 15.8 M (+0.08 %) |
Jun 06 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.39 | 12,600 | 168,764 | 15,771,614 | 15.8 M to 15.8 M (+0.08 %) |
Jun 06 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.40 | 12,600 | 168,884 | 15,594,214 | 15.6 M to 15.6 M (+0.08 %) |
Jun 06 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.39 | 12,600 | 168,764 | 15,581,614 | 15.6 M to 15.6 M (+0.08 %) |
Jun 06 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.40 | 12,600 | 168,884 | 2,025,123 | 2 M to 2 M (+0.63 %) |
Jun 06 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.39 | 12,600 | 168,764 | 2,012,523 | 2 M to 2 M (+0.63 %) |
May 22 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.50 | 50,000 | 675,000 | 15,759,014 | 15.7 M to 15.8 M (+0.32 %) |
May 22 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.50 | 50,000 | 675,000 | 15,569,014 | 15.5 M to 15.6 M (+0.32 %) |
May 22 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.50 | 50,000 | 675,000 | 1,999,923 | 1.9 M to 2 M (+2.56 %) |
May 17 2019 | NGM | NGM BIOPHARMACEUTI ... | TICHENOR MCHENRY T | Director | Option Exercise | A | 13.35 | 24,000 | 320,400 | 24,000 | |
May 17 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Option Exercise | A | 13.35 | 24,000 | 320,400 | 24,000 | |
May 17 2019 | NGM | NGM BIOPHARMACEUTI ... | SCHNELL DAVID | Director | Option Exercise | A | 13.35 | 24,000 | 320,400 | 24,000 | |
May 17 2019 | NGM | NGM BIOPHARMACEUTI ... | Hooper Suzanne Sawochka | Director | Option Exercise | A | 13.35 | 24,000 | 320,400 | 24,000 | |
May 17 2019 | NGM | NGM BIOPHARMACEUTI ... | Hooper Suzanne Sawochka | Director | Option Exercise | A | 13.35 | 38,000 | 507,300 | 38,000 | |
May 17 2019 | NGM | NGM BIOPHARMACEUTI ... | LESCHLY MARK | Director | Option Exercise | A | 13.35 | 24,000 | 320,400 | 24,000 | |
May 17 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Option Exercise | A | 13.35 | 24,000 | 320,400 | 24,000 | |
May 13 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 13.85 | 17,923 | 248,234 | 15,709,014 | 15.7 M to 15.7 M (+0.11 %) |
May 13 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 13.85 | 17,923 | 248,234 | 15,519,014 | 15.5 M to 15.5 M (+0.12 %) |
May 13 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.85 | 17,923 | 248,234 | 1,949,923 | 1.9 M to 1.9 M (+0.93 %) |
May 13 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 13.85 | 17,923 | 248,234 | 1,949,923 | 1.9 M to 1.9 M (+0.93 %) |
May 09 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 14.10 | 57,000 | 803,700 | 15,691,091 | 15.6 M to 15.7 M (+0.36 %) |
May 09 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 14.10 | 57,000 | 803,700 | 15,501,091 | 15.4 M to 15.5 M (+0.37 %) |
May 09 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 14.10 | 57,000 | 803,700 | 1,932,000 | 1.9 M to 1.9 M (+3.04 %) |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | LESCHLY MARK | Director | Option Exercise | C | 0.00 | 166,667 | 0 | 0 | |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | LESCHLY MARK | Director | Option Exercise | C | 0.00 | 600,000 | 0 | 0 | |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | LESCHLY MARK | Director | Option Exercise | C | 0.00 | 3,000,000 | 0 | 0 | |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | LESCHLY MARK | Director | Buy | C | 0.00 | 3,766,667 | 0 | 3,766,667 | 0 to 3.8 M |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Option Exercise | C | 0.00 | 3,400,000 | 0 | 0 | |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Option Exercise | C | 0.00 | 2,377,334 | 0 | 0 | |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Option Exercise | C | 0.00 | 8,408,933 | 0 | 0 | |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Option Exercise | C | 0.00 | 12,000,000 | 0 | 0 | |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | C | 0.00 | 13,093,134 | 0 | 15,444,091 | 2.4 M to 15.4 M (+556.93 %) |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 16.00 | 1,875,000 | 30,000,000 | 2,350,957 | 476 K to 2.4 M (+393.94 %) |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | Svennilson Peter | Director | Buy | P | 16.00 | 20,000 | 320,000 | 20,000 | 0 to 20 K |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Option Exercise | C | 0.00 | 3,400,000 | 0 | 0 | |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Option Exercise | C | 0.00 | 2,377,334 | 0 | 0 | |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Option Exercise | C | 0.00 | 8,488,933 | 0 | 0 | |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Option Exercise | C | 0.00 | 12,300,000 | 0 | 0 | |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | P | 16.00 | 1,875,000 | 30,000,000 | 15,634,091 | 13.8 M to 15.6 M (+13.63 %) |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | GOEDDEL DAVID V | Director | Buy | C | 0.00 | 13,283,134 | 0 | 13,759,091 | 476 K to 13.8 M (+2,790.83 %) |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Option Exercise | C | 0.00 | 3,400,000 | 0 | 0 | |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Option Exercise | C | 0.00 | 2,377,334 | 0 | 0 | |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Option Exercise | C | 0.00 | 8,408,933 | 0 | 0 | |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Option Exercise | C | 0.00 | 12,000,000 | 0 | 0 | |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 16.00 | 15,000 | 240,000 | 15,000 | 0 to 15 K |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | P | 16.00 | 1,875,000 | 30,000,000 | 1,875,000 | 0 to 1.9 M |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | COLUMN GROUP L P | 10% Owner | Buy | C | 0.00 | 13,093,134 | 0 | 13,569,091 | 476 K to 13.6 M (+2,750.91 %) |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | SCHNELL DAVID | Director | Option Exercise | C | 0.00 | 100,000 | 0 | 0 | |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | SCHNELL DAVID | Director | Option Exercise | C | 0.00 | 525,000 | 0 | 0 | |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | SCHNELL DAVID | Director | Option Exercise | C | 0.00 | 1,300,000 | 0 | 0 | |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | SCHNELL DAVID | Director | Option Exercise | C | 0.00 | 3,000,000 | 0 | 0 | |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | SCHNELL DAVID | Director | Buy | C | 0.00 | 4,925,000 | 0 | 4,925,000 | 0 to 4.9 M |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | TICHENOR MCHENRY T | Director | Option Exercise | C | 0.00 | 50,000 | 0 | 0 | |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | TICHENOR MCHENRY T | Director | Option Exercise | C | 0.00 | 166,666 | 0 | 0 | |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | TICHENOR MCHENRY T | Director | Option Exercise | C | 0.00 | 1,616,666 | 0 | 0 | |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | TICHENOR MCHENRY T | Director | Buy | C | 0.00 | 1,833,332 | 0 | 1,872,314 | 39 K to 1.9 M (+4,703.02 %) |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | Hooper Suzanne Sawochka | Director | Buy | P | 16.00 | 7,000 | 112,000 | 7,000 | 0 to 7 K |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | RIEFLIN WILLIAM JL | Executive Chairman | Option Exercise | C | 0.00 | 6,668 | 0 | 0 | |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | RIEFLIN WILLIAM JL | Executive Chairman | Option Exercise | C | 0.00 | 50,000 | 0 | 0 | |
Apr 10 2019 | NGM | NGM BIOPHARMACEUTI ... | RIEFLIN WILLIAM JL | Executive Chairman | Buy | C | 0.00 | 56,668 | 0 | 2,769,168 | 2.7 M to 2.8 M (+2.09 %) |
Apr 09 2019 | NGM | NGM BIOPHARMACEUTI ... | Merck & Co., Inc. | 10% Owner | Option Exercise | C | 0.00 | 17,666,666 | 0 | 0 | |
Apr 09 2019 | NGM | NGM BIOPHARMACEUTI ... | Merck & Co., Inc. | 10% Owner | Buy | P | 16.00 | 4,121,683 | 65,946,928 | 12,955,016 | 8.8 M to 13 M (+46.66 %) |
Apr 09 2019 | NGM | NGM BIOPHARMACEUTI ... | Merck & Co., Inc. | 10% Owner | Buy | C | 0.00 | 8,833,333 | 0 | 8,833,333 | 0 to 8.8 M |